MedCath sells out to investment house:
This article was originally published in Clinica
Executive Summary
MedCath, a provider of cardiac catheterisation services in hospitals, physicians' offices and through mobile sites, has sold out to two investment companies, Kohlberg Kravis Roberts and Welsh Carson Anderson & Stowe for $240 million in cash. MedCath was forced to find outside investors following a considerable drop in earnings projections for the year.